DEVELOPMENT OF ASSAYS FOR DETECTING DRG-DRUG INTERACTION EFFECTS AND DS (Q2035312)

From EU Knowledge Graph
Revision as of 08:06, 16 December 2021 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in fr, and other parts: Adding French translations)
Jump to navigation Jump to search
Project Q2035312 in Italy
Language Label Description Also known as
English
DEVELOPMENT OF ASSAYS FOR DETECTING DRG-DRUG INTERACTION EFFECTS AND DS
Project Q2035312 in Italy

    Statements

    0 references
    329,141.41 Euro
    0 references
    658,282.82 Euro
    0 references
    50.0 percent
    0 references
    13 December 2016
    0 references
    6 July 2019
    0 references
    FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
    0 references
    GENECHRON S.R.L.
    0 references
    0 references
    0 references
    0 references

    41°53'35.95"N, 12°28'58.55"E
    0 references
    IL PROGETTO DIHETOX NASCE DALL'ESIGENZA DI IDENTIFICARE E VALIDARE BIOMARCATORI A RNA (MIRNA O MRNA) IN GRADO DI RILEVARE PRECOCEMENTE LA PRESENZA DI DANNO AL FEGATO INDOTTO DA FARMACI O DRUG-INDUCED LIVER INJURY (DILI) (Italian)
    0 references
    THE DIETOX PROJECT STEMS FROM THE NEED TO IDENTIFY AND VALIDATE BIOMARKERS FOR RNA (MIRNA OR MRNA) ABLE TO DETECT EARLY LIVER DAMAGE CAUSED BY DRUGS OR DRUG-INDUSTRY (DILI) (English)
    0 references
    LE PROJET DIHETOX DÉCOULE DE LA NÉCESSITÉ D’IDENTIFIER ET DE VALIDER LES BIOMARQUEURS À L’ARN (MIRNA OU MRNA) CAPABLES DE DÉTECTER RAPIDEMENT LA PRÉSENCE DE LÉSIONS HÉPATIQUES INDUITES PAR LE MÉDICAMENT OU DE LÉSIONS HÉPATIQUES INDUITES PAR LE MÉDICAMENT (DILI). (French)
    16 December 2021
    0 references

    Identifiers

    F87H18000400007
    0 references